肱骨近端骨折后的死亡率——瑞典全国登记研究147,692例骨折患者
该研究基于瑞典医院出院登记和死因登记,纳入2001至2016年147,692例成人肱骨近端骨折患者,并与年龄性别匹配的人群死亡率比较。粗死亡率1个月为2.2%、12个月为8.5%、48个月为24%;全成人年龄标化死亡率比(SMR)为3.9,18-39岁组SMR最高为5.4。作者认为肱骨近端骨折患者异质性强,部分老年患者可能受益于专门照护,需未来研究评估。
要点
- 147,692例成人肱骨近端骨折患者中86%接受非手术治疗,男女比1:3,平均年龄69岁。
- 粗死亡率1个月2.2%、3个月4.1%、12个月8.5%、48个月24%。
- 年龄标化死亡率比全人群为3.9,18-39岁组最高5.4,≥80岁组最低1.2。
核心结论
- 死亡率及年龄标化死亡率比提示肱骨近端骨折患者具有异质性,部分老年患者可能受益于专门照护(如老年骨科),需未来研究评估。
研究设计与样本
- 基于瑞典医院出院登记(SHDR)和瑞典死因登记(SCDR)的全国登记研究,纳入2001至2016年所有≥18岁、诊断为肱骨近端骨折(S42.2、S42.20或S42.21)的成人患者,并与瑞典统计局提供的年龄性别匹配人群死亡率数据比较。
主要发现
- 共识别147,692例肱骨近端骨折患者,男女比1:3,平均年龄69岁(范围18至111岁),多数(n=126,487,86%)接受非手术治疗。
- 粗死亡率在骨折后1个月为2.2%、3个月为4.1%、12个月为8.5%、48个月为24%。
- 死亡率随年龄增加而升高,但标化死亡率比(SMR)在年轻患者中最高:18-39岁组5.4、40-64岁组3.9、65-79岁组1.8、≥80岁组1.2。
- 全成人肱骨近端骨折人群的年龄调整SMR为3.9。
临床怎么用
- 作者认为部分老年肱骨近端骨折患者可能受益于专门照护(如老年骨科),并应在未来研究中评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Little is known about survival after proximal humerus fracture. In this manuscript, we found the mortality to be high (almost four times higher than in age- and sex-matched controls). While frailty hip fracture has gained attention, we hope our manuscript will shed light on frailty proximal humerus fracture patients. INTRODUCTION: Proximal humerus fractures (PHF) are common and occur mostly after the 6th decade of life. While mortality following PHF has been reported previously, mortality data after longer follow-up on a national level is lacking. METHODS: We obtained data from the Swedish Hospital Discharge Register (SHDR), on all adult patients (≥ 18 years) with a diagnosis of PHF (S42.2, S42.20, or S42.21) for the period between 2001 and 2016. We used the Swedish Cause of Death Register (SCDR) to investigate mortality in the fracture cohort. We compared the mortality of fracture patients with age- and sex-matched population-based mortality data obtained from Statistics Sweden. RESULTS: A total of 147 692 PHF patients were identified, with a male to female ratio of 1:3. The mean age was 69 years (range, 18 to 111). Most patients were treated non-surgically (n = 126,487, 86%). The crude mortality rate was 2.2% at 1 month, 4.1% at 3 months, 8.5% at 12 months, and 24% at 48 months after sustaining a PHF. Mortality increased with age; however, the standardized mortality rate (SMR) was highest among young patients. SMR was 5.4 in the 18- to 39-year age group, 3.9 in the 40- to 64-year age group, 1.8 in the 65-79-year age group, and 1.2 in the ≥ 80-year-old population. The age-adjusted SMR was 3.9 in the whole adult PHF population. CONCLUSION: The mortality rate and SMR suggest that PHF patients are heterogeneous. Some older PHF patients may benefit from specialized care (e.g., orthogeriatric), and this should be evaluated in future studies.
引用
- Sumrein BO, Berg HE, Launonen AP, et al. Mortality following proximal humerus fracture-a nationwide register study of 147,692 fracture patients in Sweden. Osteoporos Int. 2022. PMID: 36435907. doi:10.1007/s00198-022-06612-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。